CIP
PAHC icon

Convergence Investment Partners’s Phibro Animal Health PAHC Stock Holding History

Convergence Investment Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,112
Closed -$449K – 331
2017
Q3 		$449K Sell
12,112
-375
-3% -$14.1K 0.06% 281
2017
Q2 		$463K Sell
12,487
-4,450
-26% -$145K 0.07% 295
2017
Q1 		$476K Buy
+16,937
New +$478K 0.07% 302
2016
Q2 		– Sell
-17,668
Closed -$478K – 364
2016
Q1 		$478K Sell
17,668
-32,160
-65% -$922K 0.06% 299
2015
Q4 		$1.5M Buy
49,828
+1,820
+4% +$58.4K 0.17% 194
2015
Q3 		$1.52M Buy
+48,008
New +$1.75M 0.17% 188

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
CRCP
Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Convergence Investment Partners's PAHC Position: Q4 2017 in Review

Convergence Investment Partners sold out of Phibro Animal Health (PAHC) in Q4 2017, closing a stake of 12,112 shares — an estimated $449K sold.

Convergence Investment Partners first reported a position in PAHC in Q3 2015 and held it in 6 quarters. The position peaked at $1.52M in Q3 2015. 169 funds tracked by Wall St. Rank hold PAHC as of Q4 2017.

  • Convergence Investment Partners reported no remaining Phibro Animal Health position as of Q4 2017 after selling out during the quarter.
  • Convergence Investment Partners sold 12,112 Phibro Animal Health shares in Q4 2017, an estimated $449K.
  • Convergence Investment Partners first reported a position in Phibro Animal Health in Q3 2015 and held it in 6 quarters.
  • Convergence Investment Partners's Phibro Animal Health position peaked at $1.52M in Q3 2015.
  • 169 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2017.

Based on Convergence Investment Partners's 13F filing for Q4 2017, filed 16 Jan 2018.